Advertisement
Advertisement
June 14, 2011
Endologix AFX Endovascular AAA System Approved by FDA
June 15, 2011—Endologix, Inc. (Irvine, CA) announced that it has received US Food and Drug Administration approval for the AFX endovascular system for the treatment of abdominal aortic aneurysms (AAA). The company is introducing AFX at the Society for Vascular Surgery's annual meeting in Chicago from June 16 to 18.
According to Endologix, AFX stent grafts range in diameter from 13 to 34 mm. The system features a hydrophilically coated 17-F introducer sheath. The sheath technology combines with the system's percutaneous 9-F contralateral access to provide a low profile for the treatment of aortic neck diameters of 22 mm or larger. An ergonomic dial mechanism allows for precise, controlled stent graft positioning and deployment. The AFX stent grafts are constructed using Endologix's Strata expanded polytetrafluoroethylene graft material, the company stated.
Advertisement
Advertisement
